Latorre A - Search Results

1

Response Predictivity to Neoadjuvant Therapies in Breast Cancer: A Qualitative Analysis of Background Parenchymal Enhancement in DCE-MRI.

La Forgia D, Vestito A, Lasciarrea M, Comes MC, Diotaiuti S, Giotta F, Latorre A, Lorusso V, Massafra R, Palmiotti G, Rinaldi L, Signorile R, Gatta G, Fanizzi A. La Forgia D, et al. Among authors: latorre a. J Pers Med. 2021 Apr 1;11(4):256. doi: 10.3390/jpm11040256. J Pers Med. 2021. PMID: 33915842 Free PMC article.

2

High efficacy of paclitaxel and doxorubicin as first-line therapy in advanced breast cancer: a phase I-II study.

De Lena M, Latorre A, Calabrese P, Catino A, Lorusso V, Mazzei A, Aloe A. De Lena M, et al. Among authors: latorre a. J Chemother. 2000 Aug;12(4):367-73. doi: 10.1179/joc.2000.12.4.367. J Chemother. 2000. PMID: 10949988 Clinical Trial.

3

Epithelial ovarian cancer: second and third line chemotherapy (review).

Latorre A, De Lena M, Catino A, Crucitta E, Sambiasi D, Guida M, Misino A, Lorusso V. Latorre A, et al. Int J Oncol. 2002 Jul;21(1):179-86. Int J Oncol. 2002. PMID: 12063566 Review.

4

Amifostine as chemoprotectant in metastatic breast cancer patients treated with doxorubicin.

Catino A, Crucitta E, Latorre A, Sambiasi D, Calabrese P, Lorusso V. Catino A, et al. Among authors: latorre a. Oncol Rep. 2003 Jan-Feb;10(1):163-7. Oncol Rep. 2003. PMID: 12469164

5

A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer.

Lorusso V, Crucitta E, Silvestris N, Guida M, Misino A, Latorre A, De Lena M. Lorusso V, et al. Among authors: latorre a. Clin Breast Cancer. 2003 Jun;4(2):138-41. doi: 10.3816/cbc.2003.n.019. Clin Breast Cancer. 2003. PMID: 12864942 Clinical Trial.

6

Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer.

Paradiso A, Mangia A, Chiriatti A, Tommasi S, Zito A, Latorre A, Schittulli F, Lorusso V. Paradiso A, et al. Among authors: latorre a. Ann Oncol. 2005 May;16 Suppl 4:iv14-19. doi: 10.1093/annonc/mdi902. Ann Oncol. 2005. PMID: 15923415 Free article.

7

Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study.

Giotta F, Lorusso V, Maiello E, Filippelli G, Valerio MR, Caruso M, Verderame F, Latorre A, Colucci G. Giotta F, et al. Among authors: latorre a. Ann Oncol. 2007 Jun;18 Suppl 6:vi66-9. doi: 10.1093/annonc/mdm228. Ann Oncol. 2007. PMID: 17591836 Free article. Clinical Trial.

8

Rapid tumor shrinkage with lapatinib plus capecitabine in a patient with massive liver involvement.

Giotta F, Latorre A, Cramarossa A, Simone G, Florio C, Oliva S, Lorusso V. Giotta F, et al. Among authors: latorre a. Tumori. 2013 Nov-Dec;99(6):278e-81e. doi: 10.1700/1390.15468. Tumori. 2013. PMID: 24503803

9

FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics.

Petroni S, Caldarola L, Scamarcio R, Giotta F, Latorre A, Mangia A, Simone G. Petroni S, et al. Among authors: latorre a. Oncol Lett. 2016 Nov;12(5):3115-3122. doi: 10.3892/ol.2016.5125. Epub 2016 Sep 13. Oncol Lett. 2016. PMID: 27899970 Free PMC article.

10

Efficacy and safety of eribulin in taxane-refractory patients in the 'real world'.

Lorusso V, Cinieri S, Latorre A, Porcu L, Del Mastro L, Puglisi F, Barni S. Lorusso V, et al. Among authors: latorre a. Future Oncol. 2017 May;13(11):971-978. doi: 10.2217/fon-2016-0530. Epub 2017 Feb 24. Future Oncol. 2017. PMID: 28326833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

549 results

Search Page

Filters